OR WAIT null SECS
Purchase of Engage grows the company’s knowledge in the data and analytics space
Fingerpaint, a commercialization partner for analytics-enabled integrated solutions in the biopharma sector, has acquired Engage, a data and analytics–enabled healthcare marketing firm. Details of the transaction were not disclosed, but Mary McGregor and Dave Chandler, both founders and managing partners of Engage, will continue to run the day-to-day operations of the business.
Per the deal, Engage will help expand Fingerpaint’s European footprint and complement the company’s current data and analytics expertise. It joins integrated Fingerpaint firms MedThink, a company that empowers healthcare providers through medical communications; Leaderboard Branding, a leading global naming and branding business; 1798, a market access and commercialization firm that specializes in healthcare consulting services, including patient and provider access services; and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies.
“Strengthening our global infrastructure is reflective of the diversified biopharma industry we serve worldwide,” says Ed Mitzen, founder of Fingerpaint. “Our combined global omnichannel marketing solutions guided by—and rooted in—data will further Fingerpaint’s position as a transformative digital partner to biopharma’s commercialization needs.”